TransMedics Group Inc (TMDX)
Receivables turnover
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 241,623 | 93,459 | 30,262 | 25,639 | 23,604 |
| Receivables | US$ in thousands | 63,576 | 27,611 | 5,934 | 6,864 | 6,559 |
| Receivables turnover | 3.80 | 3.38 | 5.10 | 3.74 | 3.60 |
December 31, 2023 calculation
Receivables turnover = Revenue ÷ Receivables
= $241,623K ÷ $63,576K
= 3.80
TransMedics Group Inc's receivables turnover ratio has exhibited some variability over the past five years. In 2023, the company's receivables turnover ratio improved to 3.80, indicating that the company collected its accounts receivable approximately 3.80 times during the year. This represents an increase from the previous year's ratio of 3.38 in 2022.
Comparing the receivables turnover ratio to earlier years, we see that in 2021, TransMedics achieved a higher turnover ratio of 5.10, reflecting a more efficient collection of accounts receivable compared to 2023. However, the ratio decreased slightly to 3.74 in 2020 and 3.60 in 2019.
Overall, the trend in TransMedics' receivables turnover implies some fluctuations but generally indicates that the company is managing its accounts receivable effectively in recent years. Investors and stakeholders may view the improvement in the receivables turnover ratio positively in 2023, suggesting a potentially stronger liquidity position and effective credit management practices.
Peer comparison
Dec 31, 2023